Re-Certification Achieved: C-RAY Enhances Radiopharmaceutical Transport Capabilities
C RAY NEWS
C-RAY has achieved a breakthrough in radiopharmaceutical supply chain optimization by obtaining China’s Radioactive Pharmaceutical Road Transport License. The company now operates a comprehensive transport network (road + air), reducing logistics costs for partners and enabling broader collaboration with research institutions.
C-RAY engineered proprietary radioactive packaging systems that passed rigorous safety tests (drop, puncture, and seal integrity) compliant with Sichuan Airlines’ air cargo standards. The hybrid ground-air transport model ensures flexible and reliable delivery across diverse scenarios.
Two C-RAY-designed containers with full IP ownership have been validated by third-party laboratories, meeting:
• GB 11806
• IAEA SSR-6
• IATA DGR
• 24–48h delivery to 90% of China’s population centers
• 72h APAC-wide coverage；
C-RAY’s advanced cold chain logistics not only ensure time-sensitive delivery and expanded coverage but also significantly reduce transport costs through operational efficiencies
The widespread adoption of novel radiopharmaceuticals relies on a synergistic ecosystem — particularly in this field, where seamless integration of R&D, production, and distribution is critical to achieving efficient cycles..
The interconnected chain of manufacturing, quality control (QC), and distribution poses challenges not only to C-RAY’s operations but also to the sustainable growth of China’s radiopharmaceutical sector.
C-RAY believes this supply chain advancement not only elevates its service capabilities but also catalyzes a mature industry ecosystem through collaborative partnerships.
C-RAY’s enhanced cold chain logistics enable broader distribution of radiopharmaceutical solutions to partners and research institutions. Since launching radiopharmaceutical R&D and manufacturing services, the company has achieved:
✅ 1 IND approval
✅ 3 INDs in active preclinical development
✅ 14 pipeline projects in research phase
In the future, C-RAY will strengthen its platform infrastructure and service capabilities, empowering deep R&D in the radiopharmaceutical field. Through collaborative partnerships with upstream and downstream enterprises, the company aims to collectively navigate the blue ocean of the radiopharmaceutical industry.
